US$ 26.99
cjc 157 ipamorelin CJC-1295 + CLP - Introducing BPC 157
Description
OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
* PS: Particle Size (nm), PDI: Polydispersity index, ZP: Zeta potential (mV), EE: Encapsulation efficiency (%), BA: Bioavailability
Chemosensors 11(6):347

Curr Health Sci J 48:110115
